These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16507346)

  • 1. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety.
    Whiteside SP; Port JD; Deacon BJ; Abramowitz JS
    Psychiatry Res; 2006 Mar; 146(2):137-47. PubMed ID: 16507346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression.
    Bédard MJ; Chantal S
    Psychiatry Res; 2011 Apr; 192(1):45-54. PubMed ID: 21377338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of behavior therapy on caudate N-acetyl-l-aspartic acid in adults with obsessive-compulsive disorder.
    Whiteside SP; Abramowitz JS; Port JD
    Psychiatry Res; 2012 Jan; 201(1):10-6. PubMed ID: 22284151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased caudate N-acetyl-l-aspartic acid in pediatric obsessive-compulsive disorder and the effects of behavior therapy.
    Whiteside SP; Abramowitz JS; Port JD
    Psychiatry Res; 2012 Apr; 202(1):53-9. PubMed ID: 22704757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between oxidative stress markers and 1H-Magnetic resonance spectroscopy findings in obsessive compulsive disorder.
    Subaşı Turgut F; Bulut M; Hattapoğlu S; Güneş M; Cemal Kaya M; Ekici F; Guli Çetinçakmak M; Kaplan İ; Atmaca M
    Brain Res; 2024 Jun; 1833():148852. PubMed ID: 38494099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered corticostriatal functional connectivity in obsessive-compulsive disorder.
    Harrison BJ; Soriano-Mas C; Pujol J; Ortiz H; López-Solà M; Hernández-Ribas R; Deus J; Alonso P; Yücel M; Pantelis C; Menchon JM; Cardoner N
    Arch Gen Psychiatry; 2009 Nov; 66(11):1189-200. PubMed ID: 19884607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder.
    Russell A; Cortese B; Lorch E; Ivey J; Banerjee SP; Moore GJ; Rosenberg DR
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S31-8. PubMed ID: 12880498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients.
    Fan Q; Tan L; You C; Wang J; Ross CA; Wang X; Zhang T; Li J; Chen K; Xiao Z
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):483-90. PubMed ID: 20923427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
    Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder.
    Yücel M; Harrison BJ; Wood SJ; Fornito A; Wellard RM; Pujol J; Clarke K; Phillips ML; Kyrios M; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2007 Aug; 64(8):946-55. PubMed ID: 17679639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional MRI comparison of patients with obsessive-compulsive disorder and normal controls during a Chinese character Stroop task.
    Nakao T; Nakagawa A; Yoshiura T; Nakatani E; Nabeyama M; Yoshizato C; Kudoh A; Tada K; Yoshioka K; Kawamoto M
    Psychiatry Res; 2005 Jul; 139(2):101-14. PubMed ID: 15970434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
    Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced prefrontal N-acetylaspartate in stroke patients with apathy.
    Glodzik-Sobanska L; Slowik A; Kieltyka A; Kozub J; Sobiecka B; Urbanik A; Szczudlik A
    J Neurol Sci; 2005 Nov; 238(1-2):19-24. PubMed ID: 16084528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study.
    Nakao T; Nakagawa A; Nakatani E; Nabeyama M; Sanematsu H; Yoshiura T; Togao O; Tomita M; Masuda Y; Yoshioka K; Kuroki T; Kanba S
    J Psychiatr Res; 2009 May; 43(8):784-91. PubMed ID: 19081580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy.
    Benazon NR; Moore GJ; Rosenberg DR
    J Am Acad Child Adolesc Psychiatry; 2003 Nov; 42(11):1279-85. PubMed ID: 14566164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration effect of obsessive-compulsive disorder on cognitive function: a functional MRI study.
    Nakao T; Nakagawa A; Yoshiura T; Nakatani E; Nabeyama M; Sanematsu H; Togao O; Yoshioka K; Tomita M; Kuroki T; Kanba S
    Depress Anxiety; 2009; 26(9):814-23. PubMed ID: 19105218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
    Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
    Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study.
    Frey BN; Stanley JA; Nery FG; Monkul ES; Nicoletti MA; Chen HH; Hatch JP; Caetano SC; Ortiz O; Kapczinski F; Soares JC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():119-27. PubMed ID: 17543030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study.
    Gilbert AR; Mataix-Cols D; Almeida JR; Lawrence N; Nutche J; Diwadkar V; Keshavan MS; Phillips ML
    J Affect Disord; 2008 Jul; 109(1-2):117-26. PubMed ID: 18342953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.